Pam/Highwire/RPM-1 (PHR) proteins are conserved from C. elegans to mammals, and play a critical role in synapse formation, axon guidance and axon termination. In C. elegans, the Regulator of Presynaptic Morphology (RPM)-1 functions with FSN-1 to negatively regulate the DLK-1 MAP kinase pathway. RPM-1 also positively regulates a Rab GTPase pathway that includes: GLO-4 and GLO-1. To further understand the mechanism of how RPM-1 functions, we biochemically purified RPM-1, and used mass spectrometry to identify RPM-1 binding proteins. Here we report the identification of RNA Export protein (RAE)-1 (also called Nuclear Pore Protein (NPP)-17) as a novel RPM-1 binding protein. The biochemical interaction between RPM-1 and RAE-1 is evolutionarily conserved as it also occurs between Pam (the human PHR protein), and rat Rae1. A conserved domain in the PHR proteins is sufficient for binding to RAE-1, and point mutations were identified that reduce binding to RAE-1.
Previous studies in yeast and mammals have shown that Rae1 functions as a cell cycle regulator, as a regulator of chromosome segregation, and as an mRNA export factor. While mammalian Rae1 and C. elegans RAE-1 are expressed in neurons, their postmitotic function remains unknown. To address the functional significance of RAE-1 binding to RPM-1, we performed a series of genetic experiments. Previous studies have shown that
rpm-1 loss of function (lf) mutants have defects in axon termination in the mechanosensory neurons, and have defects in synapse formation in the motor neurons.
rae-1(
tm2784) mutants have similar axon termination defects to
rpm-1 (lf) mutants, although they occur with lower penetrance. Double mutants of
rae-1 and other RPM-1 binding proteins, such as
fsn-1 and
glo-4, have enhanced defects in axon termination.
rae-1;
fsn-1 and
rae-1;
glo-4 double mutants also have enhanced defects in synapse formation in the GABAergic motor neurons.
rae-1;
rpm-1 double mutants are not enhanced demonstrating that
rae-1 functions in the same pathway as
rpm-1. Transgenic expression of RPM-1 that is point mutated to reduce binding to RAE-1 does not rescue axon termination defects in
rpm-1 (lf) mutants with the same efficacy as expression of wild-type RPM-1. These observations highlight the importance of RAE-1 and its interaction with RPM-1 for axon and synapse development.